Progyny grants Allison Swartz stock and options

Q: What equity awards did PGNY EVP, GC Allison Swartz receive?

On November 2, 2026, Allison Swartz received 8,160 restricted stock units and an option award covering 11,370 common shares. The option's exercise price is $29.41 per share.

Q: How do PGNY's awards to Allison Swartz vest?

Each award vests 33% on March 2, 2027, with the remainder vesting quarterly in equal installments through March 2, 2029. Vesting is subject to Allison Swartz's continued service on each applicable vesting date.

The awards vest in stages from March 2, 2027, through March 2, 2029, subject to continued service on each applicable vesting date.

Available on EDGAR 11/04/2026 - 04:19 PM EST Accepted by SEC EDGAR 11/04/2026 - 04:18 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Progyny, Inc. reported that EVP, GC Allison Swartz received 8,160 restricted stock units and an option award for 11,370 common shares on November 2, 2026. The options have an exercise price of $29.41 per share. Her reported direct common-stock holdings after the RSU award were 83,976 shares.

Insider Trade Summary

Grant/Award: 19,530 shares

Grant/Award 2 txns

Insider Swartz Allison

Role EVP, GC

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) ^F2	11,370	$0.00	$0.00
Grant/Award	Common Stock ^F1	8,160	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 11,370 contracts (Direct); Common Stock — 83,976 shares (Direct)

Footnotes (2)

F1. Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. 33% of the RSUs shall vest on March 2, 2027, with the remainder vesting quarterly in equal installments thereafter through March 2, 2029, subject to the Reporting Person's continued service on each applicable vesting date.
F2. This option shall vest as follows: 33% shall vest on March 2, 2027, with the remainder vesting quarterly in equal installments thereafter through March 2, 2029, subject to the Reporting Person's continued service on each applicable vesting date.

Key Figures

Restricted stock units awarded: 8,160 shares Option award: 11,370 shares Exercise price: $29.41 per share +1 more

4 metrics

Restricted stock units awarded 8,160 shares Awarded November 2, 2026

Option award 11,370 shares Underlying common shares; awarded November 2, 2026

Exercise price $29.41 per share Option award

Direct common-stock holdings 83,976 shares Following the RSU award on November 2, 2026

Key Terms

restricted stock units, contingent right, exercise price

3 terms

restricted stock units financial

"the grant of 8,160 restricted stock units on November 2, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right technical

"each RSU represents a contingent right to receive one share"

exercise price financial

"the option award's $29.41 per-share exercise price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did PGNY EVP, GC Allison Swartz receive?

On November 2, 2026, Allison Swartz received 8,160 restricted stock units and an option award covering 11,370 common shares. The option's exercise price is $29.41 per share.

How do PGNY's awards to Allison Swartz vest?

Each award vests 33% on March 2, 2027, with the remainder vesting quarterly in equal installments through March 2, 2029. Vesting is subject to Allison Swartz's continued service on each applicable vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Swartz Allison

(Last)

(First)

(Middle)

C/O PROGYNY, INC.

1359 BROADWAY, 2ND FL

(Street)

NEW YORK

10018

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Progyny, Inc. [ PGNY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, GC

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/02/2026		A		8,160⁽¹⁾	A	$0	83,976	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$29.41	11/02/2026		A		11,370		⁽²⁾	11/02/2036	Common Stock	11,370	$0	11,370	D

Explanation of Responses:

1. Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. 33% of the RSUs shall vest on March 2, 2027, with the remainder vesting quarterly in equal installments thereafter through March 2, 2029, subject to the Reporting Person's continued service on each applicable vesting date.

2. This option shall vest as follows: 33% shall vest on March 2, 2027, with the remainder vesting quarterly in equal installments thereafter through March 2, 2029, subject to the Reporting Person's continued service on each applicable vesting date.

Remarks:

	/s/ Mark Livingston, Attorney-in-Fact	11/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR